Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Kusaba

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Cancer Science|March 22, 2023
RHAMM marks proliferative subpopulation of human colorectal cancer stem cellsMichitaka Nakano, Ryosuke Taguchi, Yoshikane Kikushige, et al.
Japanese Journal of Clinical Oncology|November 8, 2025
Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumorsAya Takigawa, Kenji Tsuchihashi, Kenta Nio, et al.
British Journal of Cancer|March 24, 2020
OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibodyHirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2023
Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactionsKoki Uehara, Kenro Tanoue, Kyoko Yamaguchi, et al.
Medicine|June 21, 2018
A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapyHozumi Kumagai, Hitoshi Kusaba, Takeharu Yamanaka, et al.
Cancer Science|September 7, 2018
PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancerMichitaka Nakano, Mamoru Ito, Risa Tanaka, et al.
Scientific Reports|February 3, 2021
Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumabKenro Tanoue, Shingo Tamura, Hitoshi Kusaba, et al.
Medicine|October 14, 2018
Metastatic esophageal carcinosarcoma comprising neuroendocrine carcinoma, squamous cell carcinoma, and sarcoma: A case reportKenji Tsuchihashi, Shuji Arita, Minako Fujiwara, et al.
Anticancer Research|May 7, 2017
Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric CancerKyoko Inadomi, Hitoshi Kusaba, Yuzo Matsushita, et al.
FEBS Open Bio|November 19, 2019
Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancerHirofumi Ohmura, Mamoru Ito, Keita Uchino, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Cancer Science|March 22, 2023
RHAMM marks proliferative subpopulation of human colorectal cancer stem cellsMichitaka Nakano, Ryosuke Taguchi, Yoshikane Kikushige, et al.
Japanese Journal of Clinical Oncology|November 8, 2025
Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumorsAya Takigawa, Kenji Tsuchihashi, Kenta Nio, et al.
British Journal of Cancer|March 24, 2020
OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibodyHirofumi Ohmura, Kyoko Yamaguchi, Fumiyasu Hanamura, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2023
Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactionsKoki Uehara, Kenro Tanoue, Kyoko Yamaguchi, et al.
Medicine|June 21, 2018
A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapyHozumi Kumagai, Hitoshi Kusaba, Takeharu Yamanaka, et al.
Cancer Science|September 7, 2018
PD-1+ TIM-3+ T cells in malignant ascites predict prognosis of gastrointestinal cancerMichitaka Nakano, Mamoru Ito, Risa Tanaka, et al.
Scientific Reports|February 3, 2021
Predictive impact of C-reactive protein to albumin ratio for recurrent or metastatic head and neck squamous cell carcinoma receiving nivolumabKenro Tanoue, Shingo Tamura, Hitoshi Kusaba, et al.
Medicine|October 14, 2018
Metastatic esophageal carcinosarcoma comprising neuroendocrine carcinoma, squamous cell carcinoma, and sarcoma: A case reportKenji Tsuchihashi, Shuji Arita, Minako Fujiwara, et al.
Anticancer Research|May 7, 2017
Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric CancerKyoko Inadomi, Hitoshi Kusaba, Yuzo Matsushita, et al.
FEBS Open Bio|November 19, 2019
Methylation of drug resistance-related genes in chemotherapy-sensitive Epstein-Barr virus-associated gastric cancerHirofumi Ohmura, Mamoru Ito, Keita Uchino, et al.
Pageof 11